Lessons Learned From Enhancing Vaccine Pharmacovigilance Activities During PsA-TT Introduction in African Countries, 2010–2013

Background. The rollout of the group A meningococcal vaccine, PsA-TT, in Africa's meningitis belt countries represented the first introduction of a vaccine specifically designed for this part of the world. During the first year alone, the number of people who received the vaccine through mass v...

תיאור מלא

שמור ב:
מידע ביבליוגרפי
הוצא לאור ב:Clin Infect Dis
Main Authors: Diomandé, Fabien V. K., Yaméogo, Téné M., Vannice, Kirsten S., Preziosi, Marie-Pierre, Viviani, Simonetta, Ouandaogo, Claude-Roger, Keita, Modibo, Djingarey, Mamoudou H., Mbakuliyemo, Nehemie, Akanmori, Bartholomew Dicky, Sow, Samba O., Zuber, Patrick L. F.
פורמט: Artigo
שפה:Inglês
יצא לאור: Oxford University Press 2015
נושאים:
The Meningitis Vaccine Project: The Development, Licensure, Introduction, and Impact of a New Group a Meningococcal Conjugate Vaccine for Africa
גישה מקוונת:https://ncbi.nlm.nih.gov/pmc/articles/PMC4639501/
https://ncbi.nlm.nih.gov/pubmed/26553675
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/cid/civ599
תגים: הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!

פריטים דומים